Locations:

How to Recognize and Manage Post-ICU Syndrome in Neurological Practice (Podcast)

Watch for physical, psychological and cognitive manifestations

More than 20% of patients released from a medical or surgical ICU experience some cognitive dysfunction — most at the same level as someone with traumatic brain injury and up to 10% at the same level as someone with Alzheimer’s disease.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Post-ICU syndrome, which also manifests with physical and psychiatric symptoms, is an emerging phenomenon being studied by Joao Gomes, MD, Head of the Neurointensive Care Unit in Cleveland Clinic’s Cerebrovascular Center. He discusses the condition in detail in the newest episode of Cleveland Clinic’s peer-to-peer Neuro Pathways podcast.

This episode touches on:

  • How post-ICU syndrome presents and how it can affect a patient’s recovery
  • Whether patients recovering from a brain injury are more susceptible to post-ICU syndrome
  • Cleveland Clinic’s new post-ICU clinic, which will offer telemedicine visits to screen for depression, anxiety, PTSD, cognitive decline and other conditions
  • Why families of patients with post-ICU syndrome may require special attention as well
  • Helping patients recover from memory gaps and delirium with ICU diaries

Click the player below to hear the podcast, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

Excerpt from the podcast

Dr. Alex Rae-Grant (podcast host): What is post-ICU syndrome, and how did it come to be recognized?

Dr. Gomes: One has to go back primarily to literature from medical and surgical ICU populations. Some of our colleagues in those units started noticing that patients who survive an episode of sepsis or severe acute respiratory distress syndrome or respiratory failure would go back to their outpatient clinic with a lot of complaints that were not related to the primary reason for admission. They had a lot of anxiety and post-traumatic stress disorder, cognitive problems, even physical disability that was not explained by the reason for their admission. That conglomerate of symptoms and signs is what has been labeled as post-ICU syndrome.

Advertisement

Now we’ve recognized manifestations in three big areas. One is physical. Many of these patients have difficulty walking, difficulty with balance. Their stamina is certainly decreased after a major critical care episode.

The second area is psychiatric. The incidence of depression, PTSD and anxiety is quite high — up to 30% of patients admitted to a general medical or surgical ICU experience symptoms that would meet diagnostic criteria for one of these major psychiatric disorders.

The third component is cognitive. There is certainly something going on, whether it is sleep deprivation or just a systemic inflammatory response — perhaps hypoxia in some cases. Some of the medications we use for these definitely lead to cognitive decline and other symptoms.

Advertisement

Related Articles

mosquito on human skin

Rare New Neuroinvasive Threat Identified for Patients on B Cell-Depleting Therapy

Milestone case report expands understanding of infectious risks for those on immunomodulatory therapies

Head shots of Susan Linder and Karen Green
November 3, 2026/Neurosciences/Podcast

Connecting Neuro Rehab Research and Clinical Care (Podcast)

Advanced technologies are changing expectations about what’s possible

illustration of street entrance to a hospital emergency area

Architecture as a Therapeutic Tool: Acute Stroke Care in Our New Neurological Building

A rare opportunity to design for speed, care coordination, recovery and continuous monitoring

Doctor and hospital tech standing next to an older patient in a hospital bed

Inpatient Program Reduced Medication Errors in Patients With Parkinson’s Disease

Multidisciplinary, proactive approach also improved discharge outcomes

floating CAR T cell against background of other cells

Zola-Cel CAR T-Cell Therapy Shows Promising Initial Results in Multiple Sclerosis

Phase 1 Breakfree-2 trial reports good safety and efficacy at week 26

woman in lab holding two vials filled with liquids
October 19, 2026/Neurosciences/Brain Health

CSF and Plasma Analytes Reveal Early Clues to Alzheimer’s Development

Inflammatory protein eotaxin-1 may be a marker of future cognitive decline

headshots of Drs. Lilly and Barron

Early Mobilization in Neuro Intensive Care (Podcast)

Therapists and physicians collaborate to get medically stable patients moving

23-NEU-3627359-CQD-Hero-650×450

6 Things to Know About the New Home of Our Neurological Institute

Designed for digitization, distance health, discovery and more

Ad